Deerfield Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Deerfield Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-493,901	Closed	-$29.6M	–	106
2019 Q4	$29.6M	Hold	493,901	–	–	0.94%	35
2019 Q3	$13.9M	Hold	493,901	–	–	0.57%	54
2019 Q2	$18.7M	Hold	493,901	–	–	0.67%	50
2019 Q1	$19.3M	Hold	493,901	–	–	0.74%	43
2018 Q4	$10.5M	Hold	493,901	–	–	0.42%	59
2018 Q3	$19.6M	Sell	493,901 -554,529	-53%	-$20.7M	0.7%	47
2018 Q2	$40.1M	Sell	1,048,430 -336,040	-24%	-$12.4M	1.41%	19
2018 Q1	$41.6M	Buy	1,384,470 +193,954	+16%	+$6.57M	1.44%	18
2017 Q4	$37.2M	Sell	1,190,516 -334,894	-22%	-$9.19M	1.46%	23
2017 Q3	$42.7M	Sell	1,525,410 -203,858	-12%	-$4.43M	1.92%	13
2017 Q2	$33.1M	Buy	1,729,268 +325,615	+23%	+$5.2M	1.76%	19
2017 Q1	$23.9M	Hold	1,403,653	–	–	0.92%	41
2016 Q4	$25.6M	Hold	1,403,653	–	–	1.06%	35
2016 Q3	$25M	Buy	+1,403,653	New	+$21.3M	1.16%	29

Deerfield Management's BOLD Position: Q1 2020 in Review

Deerfield Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 493,901 shares — an estimated $29.6M sold.

Deerfield Management first reported a position in BOLD in Q3 2016 and held it in 14 quarters. The position peaked at $42.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Deerfield Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Deerfield Management sold 493,901 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $29.6M.
Deerfield Management first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 14 quarters.
Deerfield Management's Audentes Therapeutics, Inc position peaked at $42.7M in Q3 2017.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Deerfield Management's 13F filing for Q1 2020, filed 15 May 2020.